Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:1501-1506
Published online before print June 9, 2005, doi: 10.1161/01.STR.0000170674.45136.80
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/7/1501    most recent
01.STR.0000170674.45136.80v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grau, A. J.
Right arrow Articles by Buggle, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grau, A. J.
Right arrow Articles by Buggle, F.
Related Collections
Right arrow Acute Cerebral Hemorrhage
Right arrow Acute Cerebral Infarction

(Stroke. 2005;36:1501.)
© 2005 American Heart Association, Inc.


Original Contribution

Influenza Vaccination Is Associated With a Reduced Risk of Stroke

Armin J. Grau, MD, PhD; Beate Fischer; Cordula Barth; Paul Ling; Christoph Lichy, MD Florian Buggle, MD

From the Department of Neurology (A.J.G., F.B.), Klinikum der Stadt Ludwigshafen a.Rh., Germany; and Department of Neurology (B.F., C.B., P.L., C.L.), University of Heidelberg, Germany.

Correspondence to Armin J. Grau, MD, PhD, Department of Neurology, Klinikum der Stadt Ludwigshafen a.Rh., Bremserstr. 79, 67063 Ludwigshafen a.Rh., Germany. E-mail graua{at}klilu.de

Background and Purpose— Vascular death rates and hospitalizations for stroke are increased during influenza epidemics. Influenza vaccination may prevent stroke. We investigated whether influenza vaccination is associated independently with reduced odds of stroke and whether effects are confined to stroke subgroups and winter seasons and shared by other vaccinations.

Methods— During 18 months, we performed standardized interviews assessing vaccination status, risk factors, health-related behavior, and socioeconomic factors in 370 consecutive patients with ischemic or hemorrhagic stroke or transient ischemic attack (TIA) and 370 age- and sex-matched control subjects selected randomly from the population.

Results— Influenza vaccination during the last vaccination campaign was less common in patients (19.2%) than control subjects (31.4%; P<0.0001). After adjustment for vascular risk factors, education, health-related behavior and other factors, influenza vaccination (odds ratio [OR], 0.46; 95% CI, 0.28 to 0.77) but not other combined recent vaccinations (OR, 0.80; 95% CI, 0.42 to 1.43) were associated with reduced odds of stroke/TIA. Significant effects were found in men, older subjects (>65 years), subjects with previous vascular diseases, and regarding ischemic stroke; nonsignificant trends existed in women, younger subjects, and regarding hemorrhagic stroke. In etiologic subgroups of cerebral ischemia, similar effects were found. No protective effects were found during summer months; however, results also varied considerably between both winter seasons examined.

Conclusions— These results support the hypothesis that influenza vaccination may be associated with reduced stroke risk. However, residual confounding cannot be excluded, and interventional studies are required to evaluate the role of influenza vaccination in stroke prevention.


Key Words: infection • risk factors • stroke • stroke prevention




This article has been cited by other articles:


Home page
Circ Cardiovasc Qual OutcomesHome page
S. W. Casscells, E. Granger, A. M. Kress, A. Linton, M. Madjid, and L. Cottrell
Use of Oseltamivir After Influenza Infection Is Associated With Reduced Incidence of Recurrent Adverse Cardiovascular Outcomes Among Military Health System Beneficiaries With Prior Cardiovascular Diseases
Circ Cardiovasc Qual Outcomes, March 1, 2009; 2(2): 108 - 115.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. T. Keller, J. J. van der Meer, P. Teeling, K. van der Sluijs, M. M. Idu, G. F. Rimmelzwaan, M. Levi, A. C. van der Wal, and O. J. de Boer
Selective Expansion of Influenza A Virus-Specific T Cells in Symptomatic Human Carotid Artery Atherosclerotic Plaques
Stroke, January 1, 2008; 39(1): 174 - 179.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
R. R. S. Packard, S. Schlegel, D. Senouf, F. Burger, P. Sigaud, T. Perneger, C.-A. Siegrist, and F. Mach
Atorvastatin Treatment and Vaccination Efficacy
J. Clin. Pharmacol., August 1, 2007; 47(8): 1022 - 1027.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M. Madjid, C. C. Miller, V. V. Zarubaev, I. G. Marinich, O. I. Kiselev, Y. V. Lobzin, A. E. Filippov, and S. W. Casscells III
Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects
Eur. Heart J., May 2, 2007; 28(10): 1205 - 1210.
[Abstract] [Full Text] [PDF]